hypothyroidism. thyroid gland disorders
Conditions
Interventions
Intervention 1: During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study.
These people divided in two 25people group.
During
Treatment - Drugs
Placebo
During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study.
These people divided in two 25people group.
During the first 2 mo
During the study 50 patients who are going to the endocrinology clinic of Sari for treating their hypothyroidism enter to the study.
These people divided in two 25people group.
Each group should tak
Sponsors
Mazandaran University of Medical Sciences, Vice chancellor for research
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion: patients with hypothyroidism, up to 18 Exclusion: pregnant, GI problems, drugs which interact with levothyroxine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TSH. Timepoint: every 2 month. Method of measurement: with lab kit.;T4. Timepoint: every 2 months. Method of measurement: with lab kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary complaint. Timepoint: every 2 months. Method of measurement: request form.;Changing in weight. Timepoint: Every 2 month. Method of measurement: recuest form.;Efficacy of life. Timepoint: Every 2 month. Method of measurement: Recuest form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNeda Sasanpour
Mazandaran University of Medical Sciences, Vice chancellor for research
Outcome results
None listed